ArticleJournal of medicinal chemistry2025

Non-Catalytic Inhibitors of the p38/MK2 Interface: Repurposing Approved Drugs to Target Neuroinflammation in Alzheimer's Disease.

Maylynn Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.